.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Cipla
Julphar
Daiichi Sankyo
Queensland Health
Cantor Fitzgerald
Colorcon
McKinsey
Dow
Chubb

Generated: June 26, 2017

DrugPatentWatch Database Preview

Phenylephrine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for phenylephrine hydrochloride and what is the scope of phenylephrine hydrochloride patent protection?

Phenylephrine hydrochloride
is the generic ingredient in nine branded drugs marketed by Avadel Legacy, Paragon Bioteck, Akorn Inc, West Ward Pharm Corp, Amneal Pharms, Ani Pharms, Cenci, Vintage, G And W Labs Inc, Halsey, Hi-tech Pharmacal, Wockhardt, and Allergan, and is included in thirteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Phenylephrine hydrochloride has one patent family member in one country.

There are twenty drug master file entries for phenylephrine hydrochloride. Six suppliers are listed for this compound.

Summary for Generic Name: phenylephrine hydrochloride

Tradenames:9
Patents:2
Applicants:13
NDAs:13
Drug Master File Entries: see list20
Suppliers / Packagers: see list6
Bulk Api Vendors: see list28
Clinical Trials: see list2,397
Patent Applications: see list5,615
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phenylephrine hydrochloride at DailyMed

Pharmacology for Ingredient: phenylephrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cenci
PROMETHAZINE VC PLAIN
phenylephrine hydrochloride; promethazine hydrochloride
SYRUP;ORAL088815-001Nov 22, 1985DISCNNoNo► Subscribe► Subscribe
Avadel Legacy
VAZCULEP
phenylephrine hydrochloride
SOLUTION;IV (INFUSION)204300-003Jun 27, 2014RXYesYes► Subscribe► Subscribe
Avadel Legacy
VAZCULEP
phenylephrine hydrochloride
SOLUTION;IV (INFUSION)204300-001Jun 27, 2014RXYesNo► Subscribe► Subscribe
Ani Pharms
PHENERGAN VC
phenylephrine hydrochloride; promethazine hydrochloride
SYRUP;ORAL008604-003Apr 2, 1984DISCNYesNo► Subscribe► Subscribe
Akorn Inc
PHENYLEPHRINE HYDROCHLORIDE
phenylephrine hydrochloride
SOLUTION/DROPS;OPHTHALMIC207926-001Jan 15, 2015RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: phenylephrine hydrochloride

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2015073696► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PHENYLEPHRINE HYDROCHLORIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
923Luxembourg► SubscribePRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
C0090France► SubscribePRODUCT NAME: SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1018 20150728
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Novartis
McKesson
Cantor Fitzgerald
Deloitte
Dow
Colorcon
Chinese Patent Office
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot